CVE-2023-41974
Published: January 10, 2024· Updated: Mar 12, 2026
Official Description
A use-after-free issue was addressed with improved memory management. This issue is fixed in iOS 17 and iPadOS 17, iOS 15.8.7 and iPadOS 15.8.7. An app may be able to execute arbitrary code with kernel privileges.
Technical Analysis
CVE-2023-41974 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2023-41974 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Exploit & PoC Resources
News & Research Mentioning CVE-2023-41974
CISA has added five new vulnerabilities to its Known Exploited Vulnerabilities (KEV) Catalog, based on evidence of active exploitation. CVE-2017-7921 Hikvision Multiple Products Improper Authentication Vulnerability CVE-2021-22681 Rockwell Multiple Products Insufficient Protected Credentials Vulnerability CVE-2021-30952 Apple Multiple Products Integer Overflow or Wraparound Vulnerability CVE-2023-41974 Apple iOS and iPadOS Use-After-Free Vulnerability CVE-2023-43000 Apple Multiple products Use-After-Free Vulnerability These types of vulnerabilities are frequent attack vectors for malicious cyber actors and pose significant risks to the federal enterprise. Binding Operational Directive (BOD) 22-01: Reducing the Significant Risk of Known Exploited Vuln [xlite_meta score:60 src:CISA Alerts xlite_fp:165b5f850ff27845912a94f08bffe9b643bd34ae020914d5914015be5e7ed84e]
Quick Facts
Known Threat Actors
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2023-41974 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1